Literature DB >> 20843526

The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis.

Vicky A Legrys1, Susanna A McColley, Zhanhai Li, Philip M Farrell.   

Abstract

The proportion of insufficient sweat tests after positive newborn screening for cystic fibrosis was determined. Infants ≤ 3 months old had a mean (± standard deviation) rate of 7.2% (± 7.6) (range, 0% to 40%). Collection methods did not affect the rates. The high and variable rates indicate a need for quality improvement.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20843526      PMCID： PMC6326081          DOI： 10.1016/j.jpeds.2010.07.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  13 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

2.  New challenges in the diagnosis and management of cystic fibrosis.

Authors:  Hara Levy; Philip M Farrell
Journal:  J Pediatr       Date:  2015-06       Impact factor: 4.406

3.  A new method of sweat testing: the CF Quantum®sweat test.

Authors:  Michael J Rock; Linda Makholm; Jens Eickhoff
Journal:  J Cyst Fibros       Date:  2014-05-23       Impact factor: 5.482

4.  Proof of concept for identifying cystic fibrosis from perspiration samples.

Authors:  Zhenpeng Zhou; Daniel Alvarez; Carlos Milla; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

5.  Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.

Authors:  Theresa A Laguna; Nan Lin; Qi Wang; Bonnie Holme; John McNamara; Warren E Regelmann
Journal:  Pediatr Pulmonol       Date:  2012-01-03

6.  Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Authors:  H Levy; M Nugent; K Schneck; D Stachiw-Hietpas; A Laxova; O Lakser; M Rock; M K Dahmer; J Biller; S Z Nasr; M Baker; S A McColley; P Simpson; P M Farrell
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

7.  Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.

Authors:  Mei W Baker; Anne E Atkins; Suzanne K Cordovado; Miyono Hendrix; Marie C Earley; Philip M Farrell
Journal:  Genet Med       Date:  2015-02-12       Impact factor: 8.822

8.  Soft, skin-interfaced sweat stickers for cystic fibrosis diagnosis and management.

Authors:  Tyler R Ray; Maja Ivanovic; Paul M Curtis; Daniel Franklin; Kerem Guventurk; William J Jeang; Joseph Chafetz; Hannah Gaertner; Grace Young; Steve Rebollo; Jeffrey B Model; Stephen P Lee; John Ciraldo; Jonathan T Reeder; Aurélie Hourlier-Fargette; Amay J Bandodkar; Jungil Choi; Alexander J Aranyosi; Roozbeh Ghaffari; Susanna A McColley; Shannon Haymond; John A Rogers
Journal:  Sci Transl Med       Date:  2021-03-31       Impact factor: 17.956

Review 9.  Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.

Authors:  Adam C Seegmiller
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Improving the Rate of Sufficient Sweat Collected in Infants Referred for Sweat Testing in Michigan.

Authors:  Ibrahim Abdulhamid; Mary Kleyn; Carrie Langbo; Myrtha Gregoire-Bottex; John Schuen; Krithika Shanmugasundaram; Samya Z Nasr
Journal:  Glob Pediatr Health       Date:  2014-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.